MR MONEY MAKER: Clinigen a boost for beaten-down pharmaceuticals

It was hardly surprising that with a pandemic causing mayhem, anything and everything was pushed aside to make sure that we managed our way out of the crisis. 
And so we are now beginning to see that waiting lists for other, vital treatments have become…

Click here to view the original article.